Latest & greatest articles for sepsis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on sepsis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on sepsis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for sepsis

521. Steroids for Sepsis

Steroids for Sepsis Steroids for Sepsis – TheNNTTheNNT Systemic Steroids for Sepsis Syndromes No benefit found In Summary, for those who received the steroids: Benefits in NNT 100% saw no benefit 0% were helped by being saved from death None were helped (preventing death) Harms in NNT 0% were harmed by death, medication side effects None were harmed (increased risk of death, medication side effects) View As: NNT % Source: Efficacy Endpoints: 28-day all cause mortality, hospital mortality, ICU (...) mortality Harm Endpoints: Gastrointestinal bleeding, superinfection, hyperglycemia Narrative: Sepsis is a common and often fatal condition. A 2001 study found an incidence of 176 per 100,000 in the United States , while mortality is approximately 60% . Studies on the biological mechanisms of shock have suggested that corticosteroids may potentially be beneficial. This review examined the effect of corticosteroid therapy for severe sepsis and septic shock. 'Severe sepsis' meant documented infection

2010 theNNT

522. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis

Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

523. Rapid molecular assays for the diagnosis of sepsis and identification of sepsis causing pathogens

Rapid molecular assays for the diagnosis of sepsis and identification of sepsis causing pathogens Rapid molecular assays for the diagnosis of sepsis and identification of sepsis causing pathogens Rapid molecular assays for the diagnosis of sepsis and identification of sepsis causing pathogens Mundy L, Hiller JE Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Mundy L, Hiller JE. Rapid molecular assays for the diagnosis of sepsis and identification of sepsis causing pathogens. Adelaide: Adelaide Health Technology Assessment (AHTA). Horizon Scanning Prioritising Summary Volume 27. 2010 Authors' conclusions The Prove-it™ assay provides rapid identification of a large number of bacterial species involved in sepsis infection once sepsis has been diagnosed by conventional means. Appropriate changes in patient antimicrobial therapy may

2010 Health Technology Assessment (HTA) Database.

524. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. Full Text available with Trip Pro

Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. Goal-directed resuscitation for severe sepsis and septic shock has been reported to reduce mortality when applied in the emergency department.To test the hypothesis of noninferiority between lactate clearance and central venous oxygen saturation (ScvO2) as goals of early sepsis resuscitation.Multicenter randomized, noninferiority trial involving patients with severe sepsis

2010 JAMA Controlled trial quality: predicted high

525. Early identification of sepsis: a review of the evidence for clinical indicators and guidelines for management

Early identification of sepsis: a review of the evidence for clinical indicators and guidelines for management Early identification of sepsis: a review of the evidence for clinical indicators and guidelines for management Early identification of sepsis: a review of the evidence for clinical indicators and guidelines for management Canadian Agency for Drugs and Technologies in Health Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA (...) . No evaluation of the quality of this assessment has been made for the HTA database. Citation Canadian Agency for Drugs and Technologies in Health. Early identification of sepsis: a review of the evidence for clinical indicators and guidelines for management. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2010 Authors' conclusions Early diagnosis of sepsis: One systematic review of eight studies conducted in infants 0 to 2 months reported that signs of cyanosis, feeding difficulty

2010 Health Technology Assessment (HTA) Database.

526. Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective

Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

527. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study

A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic (...) studies means that the findings should be interpreted with caution. Authors' objectives To compare combination antibiotic therapy with monotherapy in patients with serious infections associated with sepsis and septic shock and determine if the benefits are dependent upon the risk of death. Searching MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov, SIGLE and SCOPUS were searched from inception to October 2009 for studies reported in any language. Search

2010 DARE.

528. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis

The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

529. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial

Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2010 PedsCCM Evidence-Based Journal Club

530. Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review

Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2010 PedsCCM Evidence-Based Journal Club

531. Meningococcal sepsis

Meningococcal sepsis RACGP - Meningococcal sepsis Search the RACGP website Latest issue December 2017 Vol 46(12) 881-960 Articles in the December issue discuss various health issues affecting school-aged children, including acne, eczema and growth disorders. Australian Family Physician Childhood emergencies May 2010 / / / / Focus Childhood emergencies Meningococcal sepsis Pages 276-278 Shabna Rajapaksa Mike Starr Background Meningococcal disease remains a significant illness with an overall (...) mortality of around 8%. The majority of deaths occur in the first 24 hours, before the commencement of specialist care. Missing a diagnosis of meningococcal disease is a fear among health care practitioners. Objective/s This article presents a guide to identifying the salient features of meningococcal sepsis and initial management strategies in the primary care setting. Discussion Initial presentation is often nonspecific and therefore it is important to have a high index of suspicion in children

2010 Clinical Practice Guidelines Portal

532. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients

B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2009 PedsCCM Evidence-Based Journal Club

533. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study (Abstract)

Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study OBJECTIVE To determine the impact of intrauterine inflammation of maternal (chorioamnionitis) and fetal (umbilical vasculitis) origin and neonatal sepsis on the development of neonatal chronic lung disease in preterm infants.This study was conducted at Royal Prince Alfred Hospital in Sydney, Australia. All infants born at <30 weeks' gestation, admitted to the NICU, and surviving to 36 weeks (...) ' corrected gestation during 1992-2004 were eligible. Infants with major congenital abnormalities and those without placental examination were excluded. Antenatal and perinatal data extracted from hospital databases were correlated with the independent, central neonatal database and diagnostic laboratory reports. Neonatal sepsis was categorized according to blood culture isolates into 3 groups: coagulase-negative staphylococci, other bacteria, and Candida species.There were 798 eligible infants born

2009 EvidenceUpdates

534. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study) (Abstract)

Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study) The primary aims of this study were to determine the effects of heparin on length of stay and change from baseline multiple organ dysfunction (MOD) score. Secondary objectives were to estimate the effects of heparin on 28-day all-cause mortality, and to determine the possible effect modification on 28-day all-cause mortality, in subgroups defined by site of infection and baseline values of Acute (...) not show any statistically significant reduction in 28-day mortality with UFH. There was only one serious adverse event on a patient who received heparin but it was fully resolved without complications.Our findings suggested that UFH may be a feasible and safe intervention in sepsis. However, this study was not able to demonstrate a beneficial effect on the chosen primary outcomes or in the 28-day mortality rate.

2009 EvidenceUpdates Controlled trial quality: predicted high

535. A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids?

A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids? PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2009 PedsCCM Evidence-Based Journal Club

536. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. (Abstract)

Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Neonatal sepsis and necrotizing enterocolitis (NEC) cause significant neonatal mortality and morbidity in spite of appropriate antibiotic therapy. Enhancing host defence and modulating inflammation by using lactoferrin as an adjunct to antibiotics in the treatment of sepsis and/or NEC may improve clinical outcomes.The primary objective is to assess safety and efficacy of oral lactoferrin as an adjunct (...) to antibiotics in the treatment of neonates with suspected or confirmed sepsis and/or NEC.Relevant trials in any language were searched in June 2008 in the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), MEDLINE (1966 - June 2008), PREMEDLINE, EMBASE (1980 - June 2008), CINAHL (1982 - June 2008), web sites: www.clinicaltrials.gov and www.controlled-trials.com, abstracts from the annual meeting of Pediatric Academic Societies (1990- June 2008), by contacting authors who have

2009 Cochrane

537. Procalcitonin-guided antibiotics in severe sepsis Full Text available with Trip Pro

Procalcitonin-guided antibiotics in severe sepsis Procalcitonin-guided antibiotics in severe sepsis | Critical Care | Full Text Advertisement Menu Search Search all BMC articles Search Menu We'd love your feedback. Please complete this 3 question Table of Contents , Eric B Milbrandt and Lillian L Emlet Critical Care 2008 12 :309 © BioMed Central Ltd 2008 Published: 4 December 2008 Citation Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J: Use of procalcitonin to shorten antibiotic treatment (...) duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177: 498–505 [ ]. Background The duration of antibiotic therapy in critically ill patients with sepsis can result in antibiotic overuse, increasing the risk of developing bacterial resistance. Procalcitonin (PCT)-guided antibiotic use reduces antibiotic exposure in community-acquired pneumonia. Whether it might also reduce antibiotic exposure in severe sepsis is unknown. Methods Objective To test the hypothesis

2009 Critical Care - EBM Journal Club

538. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis

The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

539. Statins for sepsis: a critical and updated review Full Text available with Trip Pro

Statins for sepsis: a critical and updated review Statins for sepsis: a critical and updated review Statins for sepsis: a critical and updated review Kopterides P, Falagas ME CRD summary This review investigated effectiveness of statins for treatment of sepsis. The authors concluded that statins had a beneficial effect on the outcome of infection, but could not make firm conclusions due to the poor quality of available data. This was an appropriate conclusion and is likely to be reliable (...) . Authors' objectives To assess the effectiveness of statins for treatment of sepsis. Searching PUBMED, EMBASE, Scopus and The Cochrane Library were searched up to 15 December 2008 without language restrictions (search terms were provided). Reference lists from identified articles, C and were searched. Study selection Studies that compared infection-related outcomes among patients who received and did not receive statins were eligible for inclusion provided they were full-text peer-reviewed articles

2009 DARE.

540. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. Full Text available with Trip Pro

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. Sepsis is a common and severe complication in premature neonates, particularly those with very low birth weight (VLBW) (<1500 g). Whether lactoferrin, a mammalian milk glycoprotein involved in innate immune host defenses, can reduce the incidence of sepsis is unknown. In animal models, the probiotic Lactobacillus rhamnosus GG (LGG) enhances the activity of lactoferrin (...) but has not been studied in human infants.To establish whether bovine lactoferrin (BLF), alone or in combination with LGG, reduces the incidence of late-onset sepsis in VLBW neonates.Prospective, multicenter, double-blind, placebo-controlled, randomized trial conducted in 11 Italian tertiary neonatal intensive care units. Patients were 472 VLBW infants enrolled from October 1, 2007, through July 31, 2008, and assessed until discharge for development of sepsis.Infants were randomly assigned to receive

2009 JAMA Controlled trial quality: predicted high